+44 1509 558 163
About Us
BioSuspensions was formed in December 2008, to exploit novel technology in the field of structured suspension systems.
The technology allows insoluble drugs to be presented
in a liquid formulation in much higher concentrations than has been
previously possible, with greater flexibility in terms of particle size,
complexity and range, lower viscosity and higher stability.
BioSuspensions was formed by BioStatus Limited, who are the main investors and majority shareholders in the company. More details about Biostatus can be found at www.biostatus.com
Board and Executive...
Stefan Ogrodzinski, CEO Biostatus, is a founding Director of BioSuspensions and is currently recruiting a Board and Executive management team to the company. For further information please contact: enquiry@biosuspensions.com